Beijing Anlong Biopharmaceutical Co., Ltd.
PrivateLast Round
Series B
Extension
Jan 7, 2026
Total Funding Raised
$58.2M
Company Overview
Beijing Anlong Biopharmaceutical Co., Ltd. is a biotechnology company that develops gene therapy products for the treatment of ophthalmological, neurological, and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Anlong Biopharmaceutical Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Beijing Anlong Biopharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 7, 2026 | ||||
| Series A Extension | Jan 23, 2024 | ||||
| Series A | Jun 9, 2021 | ||||
| VC Round | Jan 8, 2021 | ||||
| Early Funding | Jul 8, 2020 | ||||
Angel | Aug 9, 2019 |
Beijing Anlong Biopharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tigeryeah Capital | Series A |
| Oceanpine Capital | Series A, VC Round |
| Anlong Fund | VC Round |
| Shanghai Honghui Asset Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 9, 2019
$9M round led by Hangzhou Tigermed Consulting
Beijing Anlong Biopharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beijing Anlong Biopharmaceutical Co., Ltd.'s valuation, stock price, and market status.